DK330585A - Kombinationspraeparat af pyrimido-pyrimidiner og 0-acetylsalicylsyre og deres farmaceutisk acceptable salte - Google Patents

Kombinationspraeparat af pyrimido-pyrimidiner og 0-acetylsalicylsyre og deres farmaceutisk acceptable salte Download PDF

Info

Publication number
DK330585A
DK330585A DK330585A DK330585A DK330585A DK 330585 A DK330585 A DK 330585A DK 330585 A DK330585 A DK 330585A DK 330585 A DK330585 A DK 330585A DK 330585 A DK330585 A DK 330585A
Authority
DK
Denmark
Prior art keywords
pyrimido
pyrimidines
acceptable salts
acetylsalicylic acid
pharmaceutical acceptable
Prior art date
Application number
DK330585A
Other languages
English (en)
Other versions
DK164638B (da
DK330585D0 (da
DK164638C (da
Inventor
Klaus Ulrich Weithmann
Dirk Seiffge
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853515874 external-priority patent/DE3515874A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK330585D0 publication Critical patent/DK330585D0/da
Publication of DK330585A publication Critical patent/DK330585A/da
Publication of DK164638B publication Critical patent/DK164638B/da
Application granted granted Critical
Publication of DK164638C publication Critical patent/DK164638C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK330585A 1984-07-21 1985-07-19 Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat DK164638C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3426961 1984-07-21
DE3426961 1984-07-21
DE19853515874 DE3515874A1 (de) 1984-07-21 1985-05-03 Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3515874 1985-05-03

Publications (4)

Publication Number Publication Date
DK330585D0 DK330585D0 (da) 1985-07-19
DK330585A true DK330585A (da) 1986-01-22
DK164638B DK164638B (da) 1992-07-27
DK164638C DK164638C (da) 1992-12-14

Family

ID=25823162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK330585A DK164638C (da) 1984-07-21 1985-07-19 Kombinationspraeparat af pyrimido-pyrimidiner og acetylsalicylsyre og/eller deres farmaceutisk acceptable salte, fremgangsmaade til dets fremstilling samt anvendelse af pyrimido-pyrimidiner og acetylsalicylsyre og/eller salte deraf sammen med farmaceutiske baerere til fremstilling af et kombinationspraeparat

Country Status (14)

Country Link
US (1) US4694024A (da)
EP (1) EP0169465B1 (da)
JP (1) JPS6143117A (da)
AT (1) ATE50497T1 (da)
AU (1) AU574206B2 (da)
CA (1) CA1247529A (da)
DE (1) DE3576119D1 (da)
DK (1) DK164638C (da)
HU (1) HU193793B (da)
IE (1) IE58612B1 (da)
IL (1) IL75852A (da)
NZ (1) NZ212797A (da)
PH (1) PH22342A (da)
PT (1) PT80837B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US4917896A (en) * 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
DE3717337A1 (de) * 1987-05-22 1988-12-15 Hoechst Ag Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
FR2681596B1 (fr) * 1991-09-23 1993-11-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
JP2002255155A (ja) * 2001-03-06 2002-09-11 Ricoh Elemex Corp 梱包材
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
WO2004069254A2 (en) * 2003-02-07 2004-08-19 Boehringer Ingelheim International Gmbh Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders
EP1820506B1 (en) 2006-02-09 2008-03-26 Teva Pharmaceutical Industries Ltd. Dipyridamole extended-release formulations and process for preparing same
ITRM20060460A1 (it) * 2006-08-31 2006-11-30 Univ Roma Uso di acido acetil salicilico in combinazione con inibitori dei canali mrp4 per il trattamento di pazienti resistenti a detto acido acetil salicilico
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368272A1 (fr) * 1976-10-20 1978-05-19 Theramex Compositions therapeutiques solides pour combattre l'agregation plaquettaire
LU77353A1 (da) * 1977-05-16 1979-01-19
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung

Also Published As

Publication number Publication date
CA1247529A (en) 1988-12-28
DE3576119D1 (de) 1990-04-05
HUT38255A (en) 1986-05-28
EP0169465A3 (en) 1986-05-28
PH22342A (en) 1988-08-12
IE58612B1 (en) 1993-10-20
DK164638B (da) 1992-07-27
PT80837A (de) 1985-08-01
DK330585D0 (da) 1985-07-19
DK164638C (da) 1992-12-14
US4694024A (en) 1987-09-15
IE851821L (en) 1986-01-21
IL75852A0 (en) 1985-11-29
PT80837B (pt) 1987-10-20
JPH0564615B2 (da) 1993-09-16
EP0169465B1 (de) 1990-02-28
AU4519585A (en) 1986-01-23
JPS6143117A (ja) 1986-03-01
NZ212797A (en) 1988-07-28
IL75852A (en) 1990-04-29
HU193793B (en) 1987-11-30
AU574206B2 (en) 1988-06-30
EP0169465A2 (de) 1986-01-29
ATE50497T1 (de) 1990-03-15

Similar Documents

Publication Publication Date Title
AR240830A1 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
PT83508B (pt) Processo para a preparacao de composicoes farmaceuticas de accao prolongada
DK340088D0 (da) Aminosyrederivater
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
DE3668450D1 (de) 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren.
DK330585A (da) Kombinationspraeparat af pyrimido-pyrimidiner og 0-acetylsalicylsyre og deres farmaceutisk acceptable salte
DK686487D0 (da) 1h-imidazol-5-carboxylsyrederivater
NO871526L (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
DK101287D0 (da) 1h-imidazol-5-carboxylsyrederivater
DK523288D0 (da) Aminosyrederivater
DK219685A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK655487D0 (da) Furanuronsyrederivater
MX160104A (es) Procedimiento para preparar derivados de acidos quinoloncarboxilicos
ES549677A0 (es) Procedimiento para la preparacion de derivados de acidos 1- fenil-imidazol-5-carboxilicos
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
DK340485D0 (da) Phenylnonatetraensyrederivater
DK99085D0 (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK317985A (da) Aminoeburnancarboxylsyrederivater
DK355587A (da) 2-penem-3-carboxylsyre-forbindelser og salte deraf samt deres fremstilling og anvendelse
DK318085D0 (da) Nitroapovincaminsyrederivater
DK527486D0 (da) Substituerede 1-amino-cyclopropancarboxylsyrederivater
ES556359A0 (es) Procedimiento para la preparacion de nuevos derivados de la 2-halonicergolina y sus sales acidas complementarias.
NO850386L (no) N-substituerte aminopropansulfonsyrederivater
NO830981L (no) Pentandionsyrederivater og fremgangsmaate for deres fremstilling.
DK66384D0 (da) 3-deazaguaninsulfonsyresalte

Legal Events

Date Code Title Description
PBP Patent lapsed